Last reviewed · How we verify
FluMist intranasal influenza vaccine
FluMist intranasal influenza vaccine is a Biologic drug developed by Walter Reed Army Medical Center. It is currently in Phase 1 development.
At a glance
| Generic name | FluMist intranasal influenza vaccine |
|---|---|
| Sponsor | Walter Reed Army Medical Center |
| Modality | Biologic |
| Phase | Phase 1 |
Approved indications
Common side effects
- Diarrhoea
- Pyrexia
- Nasal pruritus
- Food poisoning
- Nausea
- Laryngitis
- Pharyngitis
- Dysgeusia
- Nasal congestion
- Sneezing
- Ear discomfort
- Vertigo
Key clinical trials
- pH1N1 Blinded Challenge Study (PHASE1)
- A/Texas Flu Challenge (PHASE1)
- Live Attenuated Influenza Vaccine as a Nasal Model for Influenza Infection (PHASE4)
- Bacterial Composition and Immune Responses in the Nose and Oropharynx During Influenza Infection (PHASE1)
- Establishing a Controlled Human Infection Model for Influenza H3N2 as a Foundation for Pandemic Preparedness (PHASE1)
- Intranasal LAIV Mucosal Immunity Examination (PHASE4)
- Mucosal and Systemic Immune Responses Induced by an Intranasal Influenza Live Attenuated Vaccine (PHASE4)
- Characterizing the Human Airway Immune Response to FluMist Vaccination (PHASE4)
Primary sources
Every claim on this page is sourced from regulatory or scientific primary sources. See our editorial policy for full methodology.
| Source | Used for |
|---|---|
| ClinicalTrials.gov | Trial enrolment, design, endpoints, results |
Competitive intelligence
For the full competitive landscape — auto-detected comparators, recent regulatory actions across the set, upcoming PDUFA, patent timeline, sponsor landscape:
- FluMist intranasal influenza vaccine CI brief — competitive landscape report
- FluMist intranasal influenza vaccine updates RSS · CI watch RSS
- Walter Reed Army Medical Center portfolio CI
Frequently asked questions about FluMist intranasal influenza vaccine
What is FluMist intranasal influenza vaccine?
FluMist intranasal influenza vaccine is a Biologic drug developed by Walter Reed Army Medical Center.
Who makes FluMist intranasal influenza vaccine?
FluMist intranasal influenza vaccine is developed by Walter Reed Army Medical Center (see full Walter Reed Army Medical Center pipeline at /company/walter-reed-army-medical-center).
What development phase is FluMist intranasal influenza vaccine in?
FluMist intranasal influenza vaccine is in Phase 1.
What are the side effects of FluMist intranasal influenza vaccine?
Common side effects of FluMist intranasal influenza vaccine include Diarrhoea, Pyrexia, Nasal pruritus, Food poisoning, Nausea, Laryngitis.